You are here: Industry Insights > Remdesivir

News List

Mylan to launch DESREM at Rs 4800 per vial expresspharma
July 07, 2020
Mylan will manufacture remdesivir in India at its injectables facilities, which also make product for the US.
Experts ask govt to ensure access to remdesivir, raise concerns about supply shortage expresspharma
July 07, 2020
Many also allude to an emerging black market for remdesivir in the country through which the drug is being sold at exorbitant prices per vial.
Mylan gets approval to make and market remdesivir expresspharma
July 03, 2020
Jubilant, BDR and Dr Reddy's Labs have also awaiting permission from CDSCO to manufacture and market the drug in India and are still awaiting due permission.
Gilead prices COVID-19 drug remdesivir at $2,340 per patient in developed nations expresspharma
July 01, 2020
Remdesivir is expected to be in high demand as one of the only treatments so far shown to alter the course of COVID-19.
Gilead sets Covid-19 drug candidate remdesivir price at $390 per vial pharmaceutical-technology
June 30, 2020
Gilead Sciences has set the price of its investigational Covid-19 drug remdesivir at $390 per vial for the US and governments of other developed countries.
CHMP backs approval of remdesivir as COVID-19 treatment pharmatimes
June 29, 2020
The EMA’s human medicines committee (CHMP) is backing approval of Gilead's remdesivir – under the brand name Veklury – for the treatment of COVID-19 in patients aged 12 years and over with pneumonia who require supplemental oxygen.
EMA recommends authorisation for remdesivir to combat COVID-19 europeanpharmaceuticalreview
June 28, 2020
The EMA’s human medicines committee (CHMP) has recommended a conditional marketing authorisation for Veklury (remdesivir) to treat COVID-19.
Cipla to price remdesivir version for COVID-19 under 5,000 rupees expresspharma
June 24, 2020
Indian drugmaker Cipla will price its generic version of Gilead Sciences’s antiviral drug remdesivir for use in COVID-19 patients at less than 5,000 rupees ($66), the company said.
Gilead targets remdesivir supply for two million COVID-19 patients by year-end expresspharma
June 24, 2020
The company also said it hoped to start trials in August of an easier-to-use inhaled version of the medicine, currently administered only intravenously.
Hetero announces launch of generic remdesivir ‘COVIFOR’ for COVID-19 treatment expresspharma
June 22, 2020
COVIFOR will be available in 100 mg vial (injectable) which has to be administered intravenously in a hospital setting under the supervision of a healthcare practitioner.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page